Ganguly Siddhartha; Patel Vijay
(BioMedCentral, 2008-05-30)
PURPOSE:R-CHOP (rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone) and R-CVP (rituximab with cyclophosphamide, vincristine and prednisone) have both been used successfully in the treatment of patients ...